Cargando…
Precision Oncology in Lower-Grade Gliomas: Promises and Pitfalls of Therapeutic Strategies Targeting IDH-Mutations
SIMPLE SUMMARY: Mutations of isocitrate dehydrogenase (IDH) genes are the distinctive genetic feature of lower-grade gliomas (LGGs). Tumor-associated IDH1/2 mutations result in a loss of normal enzymatic function and the abnormal production of 2-hydroxyglutarate (2-HG), which acts as an oncometaboli...
Autores principales: | Persico, Pasquale, Lorenzi, Elena, Losurdo, Agnese, Dipasquale, Angelo, Di Muzio, Antonio, Navarria, Pierina, Pessina, Federico, Politi, Letterio Salvatore, Lombardi, Giuseppe, Santoro, Armando, Simonelli, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909346/ https://www.ncbi.nlm.nih.gov/pubmed/35267433 http://dx.doi.org/10.3390/cancers14051125 |
Ejemplares similares
-
Checkpoint Inhibitors as High-Grade Gliomas Treatment: State of the Art and Future Perspectives
por: Persico, Pasquale, et al.
Publicado: (2021) -
Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytes
por: Simonelli, Matteo, et al.
Publicado: (2021) -
Conducting Phase I Trials During the SARS-Coronavirus-2 Outbreak: About Science and Care
por: Dipasquale, Angelo, et al.
Publicado: (2020) -
COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report
por: Dipasquale, Angelo, et al.
Publicado: (2021) -
Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study
por: Pessina, Federico, et al.
Publicado: (2021)